Login
Home
Charts
Search
Watchlist
Products

Bafna Pharmaceuticals Ltd

BAFNAPH·NSE
336.50+1.99%Wed, 23 Sept '26 15:16

Bafna Pharmaceuticals Ltd

BAFNAPH
NSE
336.50
+1.99%
|Wed, 23 Sept '26 15:16
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
796Cr
Close
Close Price
336.50
Industry
Industry
Pharma - Formulators
PE
Price To Earnings
102.28
PS
Price To Sales
5.58
Revenue
Revenue
143Cr
Rev Gr TTM
Revenue Growth TTM
-3.13%
PAT Gr TTM
PAT Growth TTM
-5.80%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
412841334033393535384227
Growth YoY
Revenue Growth YoY%
85.3-16.9-2.0-20.6-0.916.7-5.74.0-12.015.48.1-23.2
Expenses
ExpensesCr
373139323730363031353926
Operating Profit
Operating ProfitCr
4-23143354341
OPM
OPM%
9.8-7.37.03.69.49.38.014.612.18.08.43.3
Other Income
Other IncomeCr
011010-111122
Interest Expense
Interest ExpenseCr
011111111111
Depreciation
DepreciationCr
111122011222
PBT
PBTCr
2-31-131133230
Tax
TaxCr
000000000000
PAT
PATCr
2-31-131133230
Growth YoY
PAT Growth YoY%
54.0-198.0-72.8-111.35.7132.3-10.3570.819.193.7109.9-97.6
NPM
NPM%
6.1-10.33.5-2.26.52.93.49.88.84.86.50.3
EPS
EPS
1.1-1.20.6-0.31.10.40.61.41.30.81.20.0
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
412841334033393535384227
Growth YoY
Revenue Growth YoY%
85.3-16.9-2.0-20.6-0.916.7-5.74.0-12.015.48.1-23.2
Expenses
ExpensesCr
373139323730363031353926
Operating Profit
Operating ProfitCr
4-23143354341
OPM
OPM%
9.8-7.37.03.69.49.38.014.612.18.08.43.3
Other Income
Other IncomeCr
011010-111122
Interest Expense
Interest ExpenseCr
011111111111
Depreciation
DepreciationCr
111122011222
PBT
PBTCr
2-31-131133230
Tax
TaxCr
000000000000
PAT
PATCr
2-31-131133230
Growth YoY
PAT Growth YoY%
54.0-198.0-72.8-111.35.7132.3-10.3570.819.193.7109.9-97.6
NPM
NPM%
6.1-10.33.5-2.26.52.93.49.88.84.86.50.3
EPS
EPS
1.1-1.20.6-0.31.10.40.61.41.30.81.20.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
85654744427185115152146151143
Growth
Revenue Growth%
-15.9-23.9-27.4-7.5-2.667.719.635.532.2-4.33.3-3.1
Expenses
ExpensesCr
83708257416173100141135135131
Operating Profit
Operating ProfitCr
3-5-35-13110121611111612
OPM
OPM%
3.3-8.0-74.4-29.92.914.514.113.67.37.710.68.3
Other Income
Other IncomeCr
1131001034156
Interest Expense
Interest ExpenseCr
12117201122344
Depreciation
DepreciationCr
444334555566
PBT
PBTCr
-13-19-14-18-2651274118
Tax
TaxCr
0-12200000000
PAT
PATCr
-12-18-16-20-2651174118
Growth
PAT Growth%
-299.5-51.610.9-19.990.5410.3-10.5117.4-35.2-43.5167.3-5.8
NPM
NPM%
-14.3-28.4-34.9-45.2-4.48.26.19.84.82.97.45.5
EPS
EPS
-6.5-9.9-7.0-8.3-106.52.52.24.83.11.84.73.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
85654744427185115152146151143
Growth
Revenue Growth%
-15.9-23.9-27.4-7.5-2.667.719.635.532.2-4.33.3-3.1
Expenses
ExpensesCr
83708257416173100141135135131
Operating Profit
Operating ProfitCr
3-5-35-13110121611111612
OPM
OPM%
3.3-8.0-74.4-29.92.914.514.113.67.37.710.68.3
Other Income
Other IncomeCr
1131001034156
Interest Expense
Interest ExpenseCr
12117201122344
Depreciation
DepreciationCr
444334555566
PBT
PBTCr
-13-19-14-18-2651274118
Tax
TaxCr
0-12200000000
PAT
PATCr
-12-18-16-20-2651174118
Growth
PAT Growth%
-299.5-51.610.9-19.990.5410.3-10.5117.4-35.2-43.5167.3-5.8
NPM
NPM%
-14.3-28.4-34.9-45.2-4.48.26.19.84.82.97.45.5
EPS
EPS
-6.5-9.9-7.0-8.3-106.52.52.24.83.11.84.73.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
191924242242424242424
Reserves
ReservesCr
412217-3-7333850576172
Current Liabilities
Current LiabilitiesCr
8781597117242246545257
Non Current Liabilities
Non Current LiabilitiesCr
3942282935610131622
Total Liabilities
Total LiabilitiesCr
185167128121718690130148153176
Current Assets
Current AssetsCr
11977484836505187948590
Non Current Assets
Non Current AssetsCr
6690797235373942546886
Total Assets
Total AssetsCr
185167128121718690130148153176
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
191924242242424242424
Reserves
ReservesCr
412217-3-7333850576172
Current Liabilities
Current LiabilitiesCr
8781597117242246545257
Non Current Liabilities
Non Current LiabilitiesCr
3942282935610131622
Total Liabilities
Total LiabilitiesCr
185167128121718690130148153176
Current Assets
Current AssetsCr
11977484836505187948590
Non Current Assets
Non Current AssetsCr
6690797235373942546886
Total Assets
Total AssetsCr
185167128121718690130148153176

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-314-7-1-34-1410592215
Investing Cash Flow
Investing Cash FlowCr
-1-838433-5-7-7-15-21-22
Financing Cash Flow
Financing Cash FlowCr
4-5-31-2712-510-116
Net Cash Flow
Net Cash FlowCr
00006-7-28-62-1
Free Cash Flow
Free Cash FlowCr
-52040-1-36-202-2-60-10
CFO To PAT
CFO To PAT%
24.4-74.243.15.51,824.7-233.6186.543.7129.1533.1138.5
CFO To EBITDA
CFO To EBITDA%
-105.5-262.520.28.4-2,788.7-132.281.331.585.4198.196.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-314-7-1-34-1410592215
Investing Cash Flow
Investing Cash FlowCr
-1-838433-5-7-7-15-21-22
Financing Cash Flow
Financing Cash FlowCr
4-5-31-2712-510-116
Net Cash Flow
Net Cash FlowCr
00006-7-28-62-1
Free Cash Flow
Free Cash FlowCr
-52040-1-36-202-2-60-10
CFO To PAT
CFO To PAT%
24.4-74.243.15.51,824.7-233.6186.543.7129.1533.1138.5
CFO To EBITDA
CFO To EBITDA%
-105.5-262.520.28.4-2,788.7-132.281.331.585.4198.196.4

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
565566262325300196181177267796
Price To Earnings
Price To Earnings
55.857.517.324.642.624.1102.3
Price To Sales
Price To Sales
0.70.81.40.60.14.63.51.71.21.21.85.6
Price To Book
Price To Book
0.91.41.61.3-0.55.74.82.72.22.12.88.3
EV To EBITDA
EV To EBITDA
47.4-25.9-3.1-5.3-2.732.926.013.418.418.119.068.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
16.511.67.020.535.935.339.633.429.729.231.931.9
OPM
OPM%
3.3-8.0-74.4-29.92.914.514.113.67.37.710.68.3
NPM
NPM%
-14.3-28.4-34.9-45.2-4.48.26.19.84.82.97.45.5
ROCE
ROCE%
0.0-6.5-8.6-24.0128.09.18.214.29.26.110.910.9
ROE
ROE%
-20.5-45.1-40.6-94.942.610.38.415.49.14.911.511.5
ROA
ROA%
-6.6-11.1-12.9-16.4-2.66.75.88.85.02.76.36.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
565566262325300196181177267796
Price To Earnings
Price To Earnings
55.857.517.324.642.624.1102.3
Price To Sales
Price To Sales
0.70.81.40.60.14.63.51.71.21.21.85.6
Price To Book
Price To Book
0.91.41.61.3-0.55.74.82.72.22.12.88.3
EV To EBITDA
EV To EBITDA
47.4-25.9-3.1-5.3-2.732.926.013.418.418.119.068.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
16.511.67.020.535.935.339.633.429.729.231.931.9
OPM
OPM%
3.3-8.0-74.4-29.92.914.514.113.67.37.710.68.3
NPM
NPM%
-14.3-28.4-34.9-45.2-4.48.26.19.84.82.97.45.5
ROCE
ROCE%
0.0-6.5-8.6-24.0128.09.18.214.29.26.110.910.9
ROE
ROE%
-20.5-45.1-40.6-94.942.610.38.415.49.14.911.511.5
ROA
ROA%
-6.6-11.1-12.9-16.4-2.66.75.88.85.02.76.36.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Bafna Pharmaceuticals Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/v03wrybx6s7wbeac57zuq9gx.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/im099v4440zwn2unqa5jr1j4.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/os5gc4ah0cr9yu54zbq8mimj.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/f1q4ksoiqmlnoc81z21pimmy.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/2v3czyu1rfcxsm8517tagf3d.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/w98eswscntaxxqx5lu9be32s.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/9hiq49s93r5el8o01gg75dpp.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/pmulaamrk8amha49hi46qhgi.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/wl25c0np3vy7qq2agjx9nldw.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/9v3xh1d93ejqegi72b5jbub0.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/bd8ylsbprajdj830rpaalnej.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/4v3z2hhjh91l1swtoxi891do.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/hwvmamew0b159vnrldqjrzrs.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/ji2ij8nquin2dsz2i7u71rob.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/iidwr4q85hr1qwjxee7ug7uq.pdf